Unique ID issued by UMIN | UMIN000016597 |
---|---|
Receipt number | R000019226 |
Scientific Title | Effects of a Patient-Centered Medication Self-Management Support Program for Cancer Patients: a Mixed-Method Study |
Date of disclosure of the study information | 2015/02/27 |
Last modified on | 2020/06/15 08:33:46 |
Effects of a Patient-Centered Medication Self-Management Support Program for Cancer Patients: a Mixed-Method Study
Effects of a Medication Self-Management Support Program for Cancer Patients
Effects of a Patient-Centered Medication Self-Management Support Program for Cancer Patients: a Mixed-Method Study
Effects of a Medication Self-Management Support Program for Cancer Patients
Japan |
Breast Cancer
Hematology and clinical oncology | Breast surgery | Nursing |
Malignancy
NO
To assess the effects of a Patient-Centred Medication Self-Management Support Programme in patients receiving oral anticancer treatment, and to understand how the programme does or does not work from perceptions of intervention nurses.
Efficacy
Adherence to medication(:medication procession ratio (MPR)
:Self-efficacy,
Quality of life,
Psychological distress,
Symptoms severity and interference,
Patient satisfaction,
Emergency department visits, and hospital admissions.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
Central registration
2
Educational,Counseling,Training
Other |
We developed the Patient-Centred Medication Self-Management Support Programme consisting of three elements: information-giving using teach back, patient preference, and follow-up by nurse under the concept of concordance and shared decision making. In addition to the usual care, the intervention group will receive two sessions of the Patient-Centred Medication Self-Management Support Programme delivered by trained nurses in clinic at one month and two months. Each session will take 20 to 30 minutes.
Control groups will receive usual care.
20 | years-old | <= |
90 | years-old | > |
Male and Female
They are:(1) 20-89 years of age, (2) patients with metastatic breast cancer, (3) able to complete to the questionnaire in Japanese, (4) newly prescribed oral chemotherapy or target therapy medication, (5) able to manage medication without any assistance, or (6) having prognosis of more than three months determined by the primary physician.
They (1) have cognitive impairment or mental disorders, (2) have brain metastasis, (3) receive infusion therapy, and (4) are participants in another study.
200
1st name | |
Middle name | |
Last name | Hiroko Komatsu |
Keio University
Faculty of Nursing and Medical Care
35 Shinanomachi, Shinjukuku, Tokyo 1608582, Japan
03-5363-3733
komah@sfc.keio.ac.jp
1st name | |
Middle name | |
Last name | Kaori Yagasaki |
Keio University
Faculty of Nursing and Medical Care
35 Shinanomachi, Shinjukuku, Tokyo 1608582, Japan
03-5363-2157
yagasaki@sfc.keio.ac.jp
Keio University, Faculty of Nursing and Medical Care
Grant-in-Aid for scientific research(A)
Japanese Governmental office
Japan
YES
2014-267
National Cancer Center
26ken-29
Kanagawa Cancer Center
国立がん研究センター中央病院(東京都)、国立がん研究センター東病院(千葉県)、神奈川県立がんセンター(神奈川県),昭和大学病院(東京都)
2015 | Year | 02 | Month | 27 | Day |
Unpublished
Completed
2015 | Year | 02 | Month | 13 | Day |
2014 | Year | 11 | Month | 25 | Day |
2015 | Year | 03 | Month | 16 | Day |
2018 | Year | 07 | Month | 20 | Day |
2015 | Year | 02 | Month | 21 | Day |
2020 | Year | 06 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019226